AllianceBernstein’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,874
| Closed | -$84.6K | – | 3245 |
|
|
2024
Q1 | $84.6K | Hold |
1,874
| – | – | ﹤0.01% | 3040 |
|
|
2023
Q4 | $88.5K | Sell |
1,874
-369
| -16% | -$17.4K | ﹤0.01% | 3078 |
|
|
2023
Q3 | $90.8K | Hold |
2,243
| – | – | ﹤0.01% | 3075 |
|
|
2023
Q2 | $239K | Buy |
2,243
+743
| +50% | +$79.2K | ﹤0.01% | 2937 |
|
|
2023
Q1 | $448K | Hold |
1,500
| – | – | ﹤0.01% | 2617 |
|
|
2022
Q4 | $516K | Buy |
1,500
+144
| +11% | +$49.5K | ﹤0.01% | 2615 |
|
|
2022
Q3 | $256K | Hold |
1,356
| – | – | ﹤0.01% | 2923 |
|
|
2022
Q2 | $286K | Sell |
1,356
-1,230
| -48% | -$259K | ﹤0.01% | 2893 |
|
|
2022
Q1 | $865K | Sell |
2,586
-91,712
| -97% | -$30.7M | ﹤0.01% | 2467 |
|
|
2021
Q4 | $30.7M | Buy |
94,298
+30,532
| +48% | +$9.93M | 0.01% | 789 |
|
|
2021
Q3 | $31M | Buy |
63,766
+4,812
| +8% | +$2.34M | 0.01% | 773 |
|
|
2021
Q2 | $27.4M | Buy |
58,954
+7,961
| +16% | +$3.7M | 0.01% | 807 |
|
|
2021
Q1 | $35.2M | Buy |
50,993
+8,155
| +19% | +$5.63M | 0.02% | 718 |
|
|
2020
Q4 | $31.7M | Buy |
42,838
+5,945
| +16% | +$4.39M | 0.01% | 722 |
|
|
2020
Q3 | $25.6M | Buy |
36,893
+5,368
| +17% | +$3.72M | 0.01% | 728 |
|
|
2020
Q2 | $26.7M | Buy |
31,525
+30,756
| +3,999% | +$26.1M | 0.02% | 672 |
|
|
2020
Q1 | $275K | Buy |
+769
| New | +$275K | ﹤0.01% | 2653 |
|